News

SKAN Research Trust Earns Key Government Approvals in India

SKAN Research Trust Earns Key Government Approvals in India

SKAN Research Trust Receives Significant Government Approvals

SKAN Research Trust has recently achieved two major recognitions that highlight its commitment to advancing medical research. These recognitions are from the Government of India, designating SKAN as a Research Association for Scientific Research and recognizing it as a Scientific and Industrial Research Organization (SIRO). This acknowledgment not only validates SKAN's innovative medical approaches but also reinforces its status as one of the fastest-growing medical research organizations in the region.

Recognition Under Section 35(1) of the Income-tax Act

The Ministry of Finance has officially approved SKAN for a period of five years under the category of 'Research Association for Scientific Research', in accordance with Section 35(1)(ii) of the Income-tax Act. This approval came after an extensive evaluation by the Central Board of Direct Taxes, which scrutinized various aspects of SKAN’s operations, including its scientific outputs, laboratory practices, and innovative research initiatives. The tax benefits associated with this recognition are expected to significantly enhance donations and funding for SKAN's scientific endeavors.

Impact of the Approval on Research Funding

The approval under Section 35(1)(ii) will facilitate increased monetary support, enabling SKAN to elevate its research capabilities. This financial backing will open new avenues for groundbreaking studies, particularly in the areas of artificial intelligence applications in healthcare, bioinformatics, and other crucial health-related projects.

SIRO Designation: A Milestone Achievement

In addition to the Research Association recognition, the Department of Scientific and Industrial Research has acknowledged SKAN as a Scientific and Industrial Research Organization (SIRO). This recognition is a testament to the innovative contributions by SKAN scientists, who have published multiple patents and research papers in a variety of pivotal medical fields. The SIRO status not only boosts SKAN’s credibility but also provides several operational advantages, including customs duty exemptions on research equipment purchases.

Enhancing Research Capabilities

The SIRO designation serves as a significant milestone that will propel SKAN into a new phase of research development. With this recognition, the organization is better positioned to embark on extensive research projects, focusing on long-term solutions for chronic health conditions.

Leadership Insights on Achievements

Ashok Soota, the Chairman & Managing Trustee of SKAN, expressed his enthusiasm regarding these significant recognitions. He noted, "These various approvals have come in a short span since SKAN commenced operations. The recognition will establish SKAN's reputation as a prestigious medical research institution and enable us to plan our growth with confidence." His perspective underscores the importance of these recognitions in shaping the future ambitions of SKAN.

Furthermore, Dr. Yogesh Shouche, the Director of SKAN, affirmatively stated, "The SIRO recognition is an important milestone for SKAN. This will enable SKAN to develop major research programs and encourage our researchers to plan for mid and long term projects." These statements reveal the optimism and forward-thinking approach within the organization.

About SKAN Research Trust

Based in Bengaluru, SKAN Research Trust is a not-for-profit medical research entity that leverages transformational technologies to develop innovative therapies aimed at addressing issues such as aging, cardiovascular diseases, diabetes, and lifestyle-related disorders. The organization taps into a wide range of expertise, including genomics, stem cells, and molecular biology, to create gentler treatment protocols that are more effective and less invasive. Their mission is clear: to "Transform the future of medicine. Impacting millions of lives."

Frequently Asked Questions

What is SKAN Research Trust?

SKAN Research Trust is a not-for-profit organization focused on advancing medical research, particularly in developing therapies for various health issues.

What recognitions has SKAN recently received?

SKAN has gained recognitions as a Research Association for Scientific Research and as a Scientific and Industrial Research Organization (SIRO) by the Government of India.

How does the SIRO designation benefit SKAN?

The SIRO designation provides SKAN with customs duty exemptions on research-related equipment and boosts its credibility in the scientific community.

What are the future plans for SKAN Research Trust?

SKAN plans to embark on extensive research programs that leverage the recent government approvals to develop long-term health solutions.

Who leads SKAN Research Trust?

Mr. Ashok Soota is the Chairman & Managing Trustee, guiding SKAN's vision and strategic initiatives in medical research.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 156

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading